Nucleolar disruption and apoptosis are distinct neuronal responses to etoposide-induced DNA damage

J Neurochem. 2011 Jun;117(6):1033-46. doi: 10.1111/j.1471-4159.2011.07279.x. Epub 2011 May 13.

Abstract

Although DNA damaging topoisomerase inhibitors induce apoptosis in developing neurons, their effects on adult neurons have not yet been characterized. We report a blockage of RNA-Polymerase-1-driven transcription and nucleolar stress in neocortical neurons of adult rats after intracarotid injection of the DNA-topoisomerase-2 inhibitor, etoposide. Intracerebroventricular injection of etoposide induced a similar response in neonatal rats. In contrast, etoposide triggered neuronal apoptosis in the neonates, but not the adults. Nucleolar disruption and apoptosis were also observed in etoposide-challenged cultured cortical neurons from newborn rats. In that system, activation of the DNA double strand break signaling kinase ataxia telangiectasia-mutated protein kinase, p53 and p53-dependent apoptosis required lower etoposide concentrations than did the p53-independent induction of nucleolar stress. These distinct responses may be coupled to different forms of etoposide-induced DNA damage. Indeed, double strand breaks by the over-expressed endonuclease I-Ppo1 were sufficient to induce p53-dependent apoptosis. Moreover, nucleolar transcription was insensitive to such damage implying single strand breaks and/or topoisomerase-2-DNA adducts as triggers of nucleolar stress. Because nucleolar stress is not age-restricted, it may underlie non-apoptotic neurotoxicity of chemotherapy- or neurodegeneration-associated DNA damage by reducing ribosomal biogenesis in adult brain. Conversely, nucleolar insensitivity to double strand breaks likely contributes to mature neuron tolerance of such lesions.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Age Factors
  • Animals
  • Animals, Newborn
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / toxicity*
  • Ataxia Telangiectasia Mutated Proteins
  • Carotid Arteries
  • Cell Cycle Proteins / metabolism
  • Cell Nucleolus / drug effects*
  • Cell Nucleolus / ultrastructure
  • Cells, Cultured
  • Cerebral Cortex / cytology
  • Chromosomes, Mammalian / genetics
  • DNA Breaks, Double-Stranded
  • DNA Damage*
  • DNA-Binding Proteins / metabolism
  • Enzyme Activation
  • Etoposide / administration & dosage
  • Etoposide / toxicity*
  • Injections, Intra-Arterial
  • Injections, Intraventricular
  • Male
  • Mice
  • Neurons / drug effects*
  • Neurons / ultrastructure
  • Protein Serine-Threonine Kinases / metabolism
  • RNA Polymerase I / physiology
  • Rats
  • Rats, Sprague-Dawley
  • Topoisomerase II Inhibitors / toxicity*
  • Transcription, Genetic
  • Tumor Suppressor Protein p53 / metabolism
  • Tumor Suppressor Proteins / metabolism

Substances

  • Antineoplastic Agents
  • Cell Cycle Proteins
  • DNA-Binding Proteins
  • Topoisomerase II Inhibitors
  • Tumor Suppressor Protein p53
  • Tumor Suppressor Proteins
  • Etoposide
  • Ataxia Telangiectasia Mutated Proteins
  • Atm protein, mouse
  • Protein Serine-Threonine Kinases
  • RNA Polymerase I